Sam Products: Furnishing Precision-Engineered Cleanroom Solutions

Sanjay Batra, Founder

Sanjay Batra

Founder

The growth story of the Indian pharmaceutical indus­try, driven by an amalgamation of heightened health­care spending, government initiatives, and an inten­sified focus on R&D and technological innovation, cannot be complete without mentioning the cleanroom solutions pro­viders. According to the report ‘India Cleanroom Technology Market Size & Outlook’, India is the fastest growing regional market in the Asia Pacific and is projected to reach $445.8 million by 2030. This growth is fueled by the expansion of pharmaceutical, biotechnology, and electronics sectors, alongside increasing regulatory demands. Cleanroom solu­tions providers must leverage cutting-edge manufacturing technologies, and sustainable practices, and deliver robust customer-centric solutions to shape the future of cleanroom systems in India. Spearheading the growth trajectory of cleanroom solutions with precision-engineering solutions for more than three decades is Sam Products.

Established in 1992, Sam Products is a cleanroom solutions provider that delivers innovative and sustainable cleanroom technologies. With a focus on R&D and customer feedback, the company develops energy-efficient designs and adopts sustainable and eco-friendly materials. “We leverage data analysis to enhance product performance and deliver faster ROI for our clients”, says Sanjay Batra, Founder, Sam Products. “Products are designed for seamless assembly and configuration, effectively minimizing time and cost for clients, whether during initial implementation or retrofitting processes”, he adds. From modular designs that simplify assembly to retrofittable components that ensure compatibility with existing infrastructure, the company demonstrates an acute awareness of industry pain points and works tirelessly to resolve them.

Sam Products tailors its solutions to meet the unique demands of diverse industries, adhering to rigorous standards such as GMP and ISO 14644 compliance. Whether the requirements involve chemical resistance, microbial control, electrostatic discharge, or specialized ventilation systems, each cleanroom solution is customized to the client’s specific operational needs. The company integrates advanced technologies like biometrics, sensors, and eye scanners and is committed to innovation and adaptability to the evolving demands of the semiconductors, pharmaceuticals, and electronics industries.

Redefining Quality and Reliability

Leveraging laser cutting machines, advanced simulation tools, and the latest design software, the company ensures the highest levels of precision and efficiency in its production processes. In addition, Sam Products emphasizes waste reduction, uses recyclable materials, and adopts energy-efficient technologies such as IE4 motors, with plans to incorporate IE5 motors as soon as they are available. Environmental performance is meticulously tracked through ISO 14001-certified management systems, and life cycle assessments conducted by third-party auditors validate the company’s sustainability claims.

Quality control is guided by the company’s ISO 9001:2015 certification, which is not merely a formality but a rigorous framework that standardizes processes, pinpoints inefficiencies, and ensures consistent product reliability. Sam Products’ systems-oriented approach enables swift problem-solving, minimizes errors, and fosters accountability across all levels of the organization. By

documenting every procedure and monitoring performance metrics, it delivers on its promise of reliability. From incoming material inspections to root-cause analyses of deviations, the company ensures that its products meet the highest quality benchmarks.

Sam Products tailors its solutions to meet the unique demands of diverse industries, adhering to rigorous standards such as GMP and ISO 14644 compliance

Sanjay Batra, Founder

A key focus area for the company is its after-sales support, it consistently earns high client satisfaction ratings. It offers professional installation, on-site testing, and comprehensive training for end users. Maintenance schedules are meticulously planned, and emergency spare parts are readily available. Whether through audio-visual support, customer manuals, or periodic satisfaction surveys, the company maintains a close and proactive relationship with its clients. Its skilled technicians and maintenance teams are always on hand to address concerns, ensuring clients experience minimal downtime and maximum operational efficiency.

Unwavering Commitment to Innovation

The company is set to launch a new product line, the Tower Server, which addresses client concerns regarding space utilization, cost efficiency, and ease of use. Occupying only 30 percent of the space required by its predecessor and offering over 50 percent cost savings, the tower server exemplifies Sam Products’ ability to align product development with client priorities. While there may be a slight compromise in output efficiency, the product’s overall value proposition makes it an attractive option for cost-conscious clients.

While its solutions are already deployed across India and even in international markets through client installations, the company has identified untapped opportunities that align with its growth ambitions. With a clear roadmap to enhance product awareness, extend its footprint into unserved regions, and continue investing in research and development, Sam Products is well-positioned to scale new heights. Its alignment with government initiatives such as Make in India further underscores its dedication to contributing to national and global markets.

Excellence through Transparent Partnerships

The company has come a long way since its inception by providing versatile and future-proof solutions and fostering long-term relationships. One of the significant contributions to this growth is its trust-driven approach where it offers transparency and autonomy to its clients. “Our customers have the flexibility to purchase input materials from anywhere in the market, so they are not solely dependent on us”, says Sanjay. “By giving them this freedom, we build trust and strengthen our relationships with them”, he adds. Sam Products has garnered a robust portfolio of clients across multiple sectors, which includes Maruti Suzuki India Ltd, Tata Motors Ltd, Samsung, Cargill.

Now, the firm aims to expand product awareness and penetrate untapped markets across India. Research and development remains a core focus, with a commitment to deliver fact-based, precision-engineered solutions, particularly for suppliers working with the government. Alongside, human safety, operational efficiency, and customer satisfaction in its innovation efforts will always be top priority. Aligned with the government’s Make in India initiatives, the company is also preparing to expand its reach into global markets. As industries continue to face increasing demands for contamination control, energy efficiency, and regulatory compliance, Sam Products stands ready to combine technological advancements with a deep commitment to client satisfaction in its offerings.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.